Volpara TruDensity®
TruDensity volumetric breast density measurements PLUS a breast density category for a more objective and consistent assessment2
![Denistyonly-5-b-6.7VBD](https://www.volparahealth.com/app/uploads/2021/07/Denistyonly-5-b-6.7VBD-800x0-c-default.bmp)
Volpara Risk™ and TruDensity
Tyrer-Cuzick version 8 risk model to calculate lifetime risk of developing breast cancer3
![Scorecard-DensityAndRisk](https://www.volparahealth.com/app/uploads/2021/07/Scorecard-DensityAndRisk-800x0-c-default.bmp)
Transpara™ by ScreenPoint Medical and TruDensity
Uses machine learning to categorize mammograms by the likelihood of the presence of cancerous lesions4
![Scorecard-DensityAndTransparaOnly](https://www.volparahealth.com/app/uploads/2021/07/Scorecard-DensityAndTransparaOnly-800x0-c-default.bmp)
iCAD and TruDensity
Provides iCAD Case Score alongside Volpara TruDensity volumetric breast density and breast density category
![Scorecard-DensityAndiCAD](https://www.volparahealth.com/app/uploads/2021/07/Scorecard-DensityAndiCAD-800x0-c-default.bmp)
2. Gubern-Mérida, A., Kallenberg, M., Platel, B., Mann, R.M., Martí, R. and Karssemeijer, N. (2014) Volumetric Breast Density Estimation from Full-Field Digital Mammograms: A Validation Study. PLoS ONE; 9: e85952
3. Terry, M.B. et al. 10-year performance of four models of breast cancer risk: a validation study. Lancet Oncol 20, 504–517 (2019).
4. Rodriguez-Ruiz, et al., Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study. Eur Radiology. 2019; 29(9): pp 4825–4832